Bibliographic review of research publications on access to and use of medicines in low-income and middle-income countries in the Eastern Mediterranean Region: Identifying the research gaps

BMJ Open

Volumn 3, Issue 10, 2013, Pages

  Rashidian, Arash ^a,b   Jahanmehr, Nader ^a   Jabbour, Samer ^c   Zaidi, Shehla ^d   Soleymani, Fatemeh ^a   Bigdeli, Maryam ^e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^d AGA KHAN UNIVERSITY   (Pakistan)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; BIBLIOGRAPHIC DATABASE; DATA EXTRACTION; DATA SYNTHESIS; DJIBOUTI; EGYPT; FUNDING; HEALTH CARE SYSTEM; HUMAN; IRAN; JORDAN; LEBANON; LOWEST INCOME GROUP; MEDICAL RESEARCH; MEDLINE; MIDDLE INCOME GROUP; PAKISTAN; PUBLICATION; SCISEARCH; SOCIAL STATUS; SOMALIA; STUDY DESIGN; SUDAN;

EID: 84886690522     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003332     Document Type: Article

References (60)

1. Wagner AK, Graves AJ, Reiss SK, et al. Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey. Health Policy 2011;100:151-8.
2. Laing R, Waning B, Maculey C, et al. Improving access to child health medicines: review and discussion paper for WHO Regional and Country Child Health Advisors. Geneva: WHO, 2002.
3. MDG Gap Task force Report. Delivering on the global partnership for achieving the millennium development goals. United Nations University Press 2008.
4. Videau JY. Access for all to quality drugs. Med Trop (Mars) 2002;62:396-400.
5. Tumwikirize WA, Ogwal-Okeng JW, Vernby O, et al. Access and use of medicines information sources by physicians in public hospitals in Uganda: a cross-sectional survey. Afr Health Sci 2008;8:220-6.
6. Emmerick ICM, Oliveira MA, Luiza VL, et al. Access to medicines in Latin America and the Caribbean (LAC): a scoping study. BMJ Open 2013;3:e002224.
7. Cameron A, Ewen M, Ross-Degnan D, et al. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 2009;373:240-9.
8. WHO Medicines Strategy: Countries at the Core 2004-2007. WHO/EDM/2004.2.
9. Medicines use in primary care in developing and transitional countries: fact book summarising results from studies reported between 1990 and 2006. WHO/EMP/MAR/2009.3.
10. Zaidi S, Aleem N, Bigdeli M, et al. Access to essential medicines in Pakistan: policy and health systems research concerns. PLoS ONE 2013;8:e63515.
11. Hanson K, Ranson MK, Oliveira-Cruz V, et al. Expanding access to priority health interventions: a framework for understanding the constraints to scaling-up. J Int Dev 2003;15:1-14. (Pubitemid 36175340)
12. Anonymous. WHO Framework for developing a health systems research agenda. http://www.who.int/rpc/meetings/Framework-for-developing-a-health-systems- research-agenda.pdf (accessed May 2013).
13. WHO. Equitable access to essential medicines: a framework for collective action. Geneva: WHO Policy Perspectives on Medicines, No. 008, 2004.
14. Wagner JL, McCarthy E. International differences in drug prices. Annu Rev Public Health 2004;25:475-95. (Pubitemid 38543628)
15. Vasan A, Hoos D, Mukherjee JS, et al. The pricing and procurement of antiretroviral drugs: an observational study of data from the Global Fund. Bull World Health Organ 2006;84:393-8.
16. Hogerzeil HV, Samson M, Casanovas JV, et al. Is access to essential medicines as part of the fulfilment of the right to health enforceable through the courts? Lancet 2006;368:305-11. (Pubitemid 44067247)
17. Vreeman RC, Wiehe SE, Pearce EC, et al. A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries. Pediatr Infect Dis J 2008;27686-91.
18. Suh G-H. High medicine prices and poor affordability. Curr Opin Psychiatry 2011;24:341-5.
19. Kishore SP, Vedanthan R, Fuster V. Promoting global cardiovascular health. J Am Coll Cardiol 2011;57:1980-7.
20. Berendes S, Heywood P, Oliver S, et al. Quality of private and public ambulatory health care in low and middle income countries: systematic review of comparative studies. PLoS Med 2011;8:e1000433.
21. Faden L, Vialle-Valentin C, Ross-Degnan D, et al. Active pharmaceutical management strategies of health insurance systems to improve cost-effective use of medicines in low- and middle-income countries: a systematic review of current evidence. Health Policy 2011;100:134-43.
22. Renaud-Thery F, Avila-Figueroa C, Stover J, et al. Utilization patterns and projected demand of antiretroviral drugs in low-and middle-income countries. AIDS Res Treat 2011;2011: 749041.
23. Machado M, O'Brodovich R, Krahn M, et al. International drug price comparisons: quality assessment. Rev Panam Salud Publica 2011;29:46-51.
24. Hoen E, Berger J, Calmy A, et al. Driving a decade of change: HIV/AIDS, patents and access to medicines for all. J Int AIDS Soc 2011;14:15.
25. Zargarzadeh AH, Emami MH, Hosseini F. Drug-related hospital admissions in a generic pharmaceutical system. Clin Exp Pharmacol Physiol 2007;34:494-8. (Pubitemid 46494476)
26. Zargarzadeh AH, Minaeiyan M, Torabi A. Prescription and nonprescription drug use in Isfahan, Iran: an observational, cross-sectional study. Curr Ther Res Clin Exp 2008;69:76-87. (Pubitemid 351446017)
27. Khan MS, Ahmed Z, Jehan S, et al. Common trend of antibiotics usage in a tertiary care hospital of Peshawar, Pakistan. J Ayub Med Coll Abbottabad 2010;22:118-20.
28. Al-Niemat SI, Bloukh DT, Al-Harasis MD, et al. Drug use evaluation of antibiotics prescribed in a Jordanian hospital outpatient and emergency clinics using WHO prescribing indicators. Saudi Med J 2008;29:743-8.
29. Yousif MA, Nizar S, Elmustafa MO, et al. Investigation of medication prescribing errors in Wad Medani, Gezira, Sudan. Int J Risk Saf Med 2011;23:11-16.
30. Saab YB, Hachem A, Sinno S, et al. Inappropriate medication use in elderly Lebanese outpatients: prevalence and risk factors. Drugs Aging 2006;23:743-52. (Pubitemid 44536908)
31. Fattouh R, Abu Hamad B. Impact of using essential drug list: analysis of drug use indicators in Gaza Strip. East Mediterr Health J 2010;16:886-92.
32. Sepehri G, Talebizadeh N, Mirzazadeh A, et al. The patterns of antihypertensive drug prescription by cardiologists in Kerman province of Iran, 2006. Pharmacoepidemiol Drug Saf 2008;17:180-5. (Pubitemid 351308517)
33. Abu Rumman K, Ottmani S, Abu Sabra N, et al. Training on the practical approach to lung health: effect on drug prescribing in PHC settings in Jordan. East Mediterr Health J 2009;15:111-21.
34. Al-Taiar A, Jaffar S, Assabri A, et al. Who develops severe malaria? Impact of access to healthcare, socio-economic and environmental factors on children in Yemen: a case-control study. Trop Med Int Health 2008;13:762-70. (Pubitemid 351678634)
35. Davari M, Walley T, Haycox A. Pharmaceutical policy and market in Iran: past experiences and future challenges. J Pharm Health Serv Res 2011;2:47-52.
36. Esmaily HM, Savage C, Vahidi R, et al. Identifying outcome-based indicators and developing a curriculum for a continuing medical education programme on rational prescribing using a modified Delphi process. BMC Med Educ 2008;8:33.
37. Fahimi F, Sahraee Z, Amini S. Evaluation of stat orders in a teaching hospital. Clin Drug Investig 2011;31:231-5.
38. Hamidi S, Younis MJ, Forgione DA. Implementing an essential medicines list: effects on pricing and utilization in West Bank, Palestine. J Health Care Finance 2008;34:10-30. (Pubitemid 351831873)
39. Lowe RF, Montagu D. Legislation, regulation, and consolidation in the retail pharmacy sector in low-income countries. South Med Rev 2009;2:35-44.
40. Khawaja MR, Majeed A, Malik F, et al. Prescription pattern of benzodiazepines for inpatients at a tertiary care university hospital in Pakistan. J Pak Med Assoc 2005;55:259.
41. Ritz LS, Adam T, Laing R. A bibliometric study of publication patterns in access to medicines research in developing countries. South Med Rev 2010;3:2-6.
42. Yousefi Nooraie R, Rashidian A, Nedjat S, et al. Promoting development and use of systematic reviews in a developing country. J Eval Clin Practice 2009;15:1029-34.
43. Zaidi S, Bigdeli M, Aleem N, et al. Access to essential medicines in Pakistan: policy and health systems research concerns. PLoS ONE 2013;8:e63515.
44. Wagner AK, Graves AJ, Reiss S, et al. Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey. Health Policy 2010;100:151-8.
45. Mirza Z. Thirty years of essential medicines in primary health care. East Mediterr Health J 2008;14(Suppl):S74-81.
46. Takian A, Rashidian A, Kabir MJ. Expediency and coincidence in reengineering a health system: an interpretive approach to formation of family medicine in Iran. Health Policy Plann 2011;26:163-73.
47. Kavosi Z, Rashidian A, Pourreza A, et al. Inequality in household catastrophic health care expenditure in a low-income society of Iran. Health Policy Plan 2012;27:613-23.
48. Management Sciences for Health. MDS-3: managing access to medicines and health technologies. Alrington, VA: Management Sciences for Health, 2012.
49. RJea EJ. WHO/HAI Project on Medicine Prices and Availability. World Health Organization and Health Action International, 2011.
50. Cameron A, Roubos I, Ewen M, et al. Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bull World Health Organ 2011;89:412-21.
51. Sawalha AF, Sweileh WM, Zyoud SH, et al. Analysis of prescriptions dispensed at community pharmacies in Nablus, Palestine. East Mediterr Health J 2010;16:788-92.
52. Penn-Barwell J, Pengelly S. Audit of prescription of anti-malarial prophylaxis to patients admitted to Royal Centre for Defence Medicine (RCDM) following evacuation from Afghanistan. J R Nav Med Serv 2008;94:112-14.
53. Yousif E, Ahmed AM, Abdalla ME, et al. Deficiencies in medical prescriptions in a Sudanese hospital. East Mediterr Health J 2006;12:915-18. (Pubitemid 46358290)
54. Kuemmerle A, Dodoo AN, Olsson S, et al. Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring. Malar J 2011;10:57.
55. Smith F. The quality of private pharmacy services in low and middle-income countries: a systematic review. Pharm World Sci 2009;31:351-61.
56. Soleymani F, Rashidian A, Dinarvand R, et al. Assessing the effectiveness and cost-effectiveness of audit and feedback on physician's prescribing indicators: study protocol of a randomized controlled trial with economic evaluation. DARU J Pharm Sci 2012;20:88.
57. Rahimi B, Timpka T. Pharmacists' views on integrated electronic prescribing systems: associations between usefulness, pharmacological safety, and barriers to technology use. Eur J Clin Pharmacol 2011;67:179-84.
58. Esmaily HM, Silver I, Shiva S, et al. Can rational prescribing be improved by an outcome-based educational approach? A randomized trial completed in Iran. J Contin Educ Health Prof 2010;30:11-18.
59. Garjani A, Salimnejad M, Shamsmohamadi M, et al. Effect of interactive group discussion among physicians to promote rational prescribing. East Mediterr Health J 2009;15:408-15.
60. Large M, Farooq S, Nielssen O, et al. Relationship between gross domestic product and duration of untreated psychosis in low- and middle-income countries. Br J Psychiatry 2008;193:272-8.